Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pritesh Desai

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Science Translational Medicine|August 21, 2024
Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2 in micePritesh Desai, Courtney E Karl, Baoling Ying, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2Pritesh Desai, Courtney E Karl, Baoling Ying, et al.
Cell|April 4, 2025
Rorγt-positive dendritic cells are required for the induction of peripheral regulatory T cells in response to oral antigensPatrick Fernandes Rodrigues, Shitong Wu, Tihana Trsan, et al.
Cell Reports. Medicine|January 31, 2026
An intranasal adenoviral-vectored vaccine protects against highly pathogenic avian influenza H5N1 in naive and antigen-experienced animalsBaoling Ying, Kelly Pyles, Tamarand L Darling, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2022
The aryl hydrocarbon receptor instructs the immunomodulatory profile of a subset of Clec4a4<sup>+</sup> eosinophils unique to the small intestineWei-Le Wang, Jun Kasamatsu, Satoru Joshita, et al.
Science (New York, N.Y.)|November 10, 2018
WDFY4 is required for cross-presentation in response to viral and tumor antigensDerek J Theisen, Jesse T Davidson, Carlos G Briseño, et al.
Immunity|May 18, 2021
Differential usage of transcriptional repressor Zeb2 enhancers distinguishes adult and embryonic hematopoiesisXiao Huang, Stephen T Ferris, Sunkyung Kim, et al.
JCI Insight|January 4, 2024
Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activityOfer Zimmerman, Alexa Michelle Altman Doss, Baoling Ying, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Science Translational Medicine|August 21, 2024
Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2 in micePritesh Desai, Courtney E Karl, Baoling Ying, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2Pritesh Desai, Courtney E Karl, Baoling Ying, et al.
Cell|April 4, 2025
Rorγt-positive dendritic cells are required for the induction of peripheral regulatory T cells in response to oral antigensPatrick Fernandes Rodrigues, Shitong Wu, Tihana Trsan, et al.
Cell Reports. Medicine|January 31, 2026
An intranasal adenoviral-vectored vaccine protects against highly pathogenic avian influenza H5N1 in naive and antigen-experienced animalsBaoling Ying, Kelly Pyles, Tamarand L Darling, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2022
The aryl hydrocarbon receptor instructs the immunomodulatory profile of a subset of Clec4a4<sup>+</sup> eosinophils unique to the small intestineWei-Le Wang, Jun Kasamatsu, Satoru Joshita, et al.
Science (New York, N.Y.)|November 10, 2018
WDFY4 is required for cross-presentation in response to viral and tumor antigensDerek J Theisen, Jesse T Davidson, Carlos G Briseño, et al.
Immunity|May 18, 2021
Differential usage of transcriptional repressor Zeb2 enhancers distinguishes adult and embryonic hematopoiesisXiao Huang, Stephen T Ferris, Sunkyung Kim, et al.
JCI Insight|January 4, 2024
Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activityOfer Zimmerman, Alexa Michelle Altman Doss, Baoling Ying, et al.
Pageof 4